IL6R and rheumatoid arthritis: Given that both SOCS3 and IL6R play a key role in the IL-6 signaling pathway, the main aim of the current study was to investigate whether the methylation patterns of SOCS3 and IL6R promoters are associated with the morbidity and severity of RA.